Background {#Sec1}
==========

Over the past 15 years, the mortality rate from severe sepsis and septic shock has been declining \[[@CR1]--[@CR5]\]. With this decreased mortality rate, clinicians are now focusing increasing efforts on reducing sepsis-related morbidity, including intensive care unit (ICU)-acquired delirium.

Delirium in the ICU is a prevalent problem, occurring in up to 80 % of patients \[[@CR6]\]. The etiology is thought to be multifactorial including the effects of lack of sleep, noise in the ICU, use of sedatives and analgesics, and sepsis related to infection \[[@CR7]--[@CR9]\]. Cerebral hypoxia could be a potential cause of delirium in ICU patients. There is emerging data from the anesthesia literature suggesting that occult intraoperative cerebral hypoxia results in postoperative morbidity, including postoperative cognitive dysfunction \[[@CR10]--[@CR13]\]. These decreases in brain tissue oxygen saturation (SctO~2~) can be measured non-invasively with cerebral oximetry. In the operative environment, cerebral desaturations usually occur in the absence of systemic hypoxemia \[[@CR13]\]. The question of whether cerebral desaturations occur in ICU patients (and in particular, septic shock patients) and what, if any, consequences these may have is untested.

During the resuscitative phase of septic shock, a low cardiac output state occurs. During these low flow states, the regional distribution of blood flow to vital organs such as the brain occurs at the expense of other tissue beds such as the kidney and splanchnic circulation \[[@CR14], [@CR15]\]. A reliable non-invasive continuous perfusion monitor has not been utilized in patients with shock.

In this single-center prospective observational trial, our primary objective was to determine if the incidence and magnitude of cerebral desaturations in septic shock patients correlated with delirium, as measured by the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score \[[@CR16]\]. Secondary outcomes examined were the association between the incidence and magnitude of cerebral desaturations and acute kidney injury (AKI) or death (up to 28 days after the diagnosis of sepsis). We also compared the incidence and magnitude of cerebral desaturations in patients with septic shock with patients undergoing high-risk non-cardiac surgical procedures, a group known to be at high risk for cerebral desaturations and high risk for complications \[[@CR10], [@CR17]\].

Methods {#Sec2}
=======

This trial was registered at Clinicaltrials.gov as NCT1836302. After approval by the University of Manitoba Biomedical Research Ethics Board, we recruited all patients over the age of 18 years who had been admitted to either the Medical or Surgical/Trauma ICU at the University of Manitoba Health Sciences Center with the diagnosis of severe sepsis and septic shock for a 6-month period. Written consent for inclusion in the study was obtained from the patient's family on a deferred basis.

The definition of severe sepsis and septic shock was based on the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee \[[@CR18]\]. Patients were treated according to the Surviving Sepsis Guidelines with early antimicrobial therapy and source control, aggressive fluid resuscitation, mechanical ventilation, and hemodynamic support \[[@CR19]\].

Patients with severe sepsis and septic shock had bilateral near-infrared spectroscopic cerebral oximiter sensors (Foresight®, CASMED, Brandford, CT, USA) placed on their forehead. Sensors were placed within 12 h of the patients being admitted to the ICU in order to capture any desaturations that might occur during the resuscitative phase of their septic shock. Sensors were kept in place for at least 24 h, with a maximum monitoring time of 48 h. If a patient regained hemodynamic stability (as defined as no longer needing vasopressor support) after 24 h, monitoring was discontinued. The monitoring was also discontinued and reinstituted in order to facilitate travel for diagnostic imaging or other procedures outside the ICU.

Cerebral saturation data were collected continuously at 0.5 Hz. After the study period ended, the data were downloaded from the monitor and placed into a Microsoft Excel (Redmond, WA) spreadsheet and the values were averaged on an hourly basis. Hemodynamic values and vasopressor doses were recorded hourly.

Patients were sedated to a RASS goal of −1 to −2 as per institutional protocol (typically with a combination of either propofol, fentanyl, or midazolam infusions). The CAM-ICU assessment was measured twice daily for the duration of ICU stay. Daily interruption of sedation was not performed. The CAM-ICU assessment occurred for several more days after SctO~2~ monitoring was discontinued in an attempt to capture the potential for delayed effects of decreases in SctO~2~ on the incidence of delirium.

Baseline demographic data on each patient was collected. In addition to SctO~2~, levels, other patient variables that were collected included hourly blood pressure, hourly vasopressor requirements, fraction of inspired oxygen, and peripheral oxygen saturation. Sequential organ failure assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores were also collected for each patient.

Outcome variables measured included the presence of delirium as determined by a positive Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score, acute kidney injury (using the AKIN criteria \[[@CR20]\]), the need for two or more vasopressors/inotropes, and ICU mortality.

As a comparator group, the incidence and magnitude of cerebral desaturations was compared with data from a concurrent trial of patients undergoing high-risk non-cardiac surgical procedures utilizing the same monitor (NCT01838733). This is a patient group that is known to be at high risk for cerebral desaturations \[[@CR10], [@CR17]\].

Availability of data and materials {#Sec3}
----------------------------------

Our research ethics board does not allow the release of databases without consent. These will not be available to readers.

Statistical analysis {#Sec4}
--------------------

As the definition of cerebral desaturation varies from study to study, we examined several exploratory markers of desaturation including overall number of desaturations (to less than \< 65 %), nadir cerebral saturation (SctO~2~), percent time under threshold (defined as the percentage of time spent below an SctO~2~ level of 65 %, to account for variable recording lengths between patients), and the area under threshold (AUT; a measurement that takes into account the time below a threshold, as well as the magnitude of the decrease in SctO~2~, units of %-min). Values of AUT were divided by the total recording time for patients to obtain values on a per hour basis to take into account the varied recording times.

In examining the relationship between changes in hemoglobin level and SctO~2~, we examined various SctO~2~ thresholds at 5 % intervals (60--75 %) to determine which cutoff had the highest correlation with change in day 2 hemoglobin.

As this was a pilot study, we calculated our sample size based on the method of Viechtbauer et al. \[[@CR21]\]. A previous work in high-risk surgical patients has demonstrated a cerebral desaturation rate of 20 % \[[@CR10], [@CR12], [@CR17], [@CR22], [@CR23]\]. Assuming a similar incidence in patients with septic shock, we determined that studying 14 patients would give us 95 % confidence to detect a 20 % probability of desaturations.

Statistical analysis was performed using GraphPad Prism version 6.0 (GraphPad Software Inc., La Jolla, CA, USA). Categorical variables were analyzed with the Fisher exact test. Between group continuous variables were analyzed with a Student *t* test or a Mann-Whitney *U* test, depending on the distribution of the data. The Kolmogorov-Smirnov test was performed to assess for normality. Continuous data are presented as mean ± standard deviation or median \[interquartile range\]. Correlations between SctO~2~ and SOFA and APACHE II scores were compared using a Spearman correlation test. A *p* value of 0.05 was considered significant.

Results {#Sec5}
=======

During our 6-month pilot trial, we enrolled 15 patients with septic shock (see Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). The average age of the patients was 57 ± 14 years. Median \[interquartile range\] for SOFA and APACHE II scores were 15 \[12--19\] and 23 \[18--26\], respectively. Pneumonia was the most common cause of sepsis, occurring in seven out of the 15 (47 %) patients. Eight of the 15 patients (53 %) had a causative organism identified (see Table [1](#Tab1){ref-type="table"}). Thirteen of the patients (87 %) were mechanically ventilated and all were receiving vasopressor support with norepinephrine. Ten (67 %) were also receiving concomitant therapy with vasopressin. Seven of the 15 patients (47 %) were CAM-ICU positive, and 10 developed an AKI. There were four deaths in the septic shock group.Table 1Baseline data for the patients with septic shockPatientPMHxSource of sepsisOrganismOutcomeCAMAKISOFAAPACHEMechanical ventilation1EtOH abuseLungNone recoveredDeadCAM+Yes2324Yes2HIV, IHDLung*Streptococcus pneumoniae*AliveCAM−Yes1528Yes3CHFLungNone recoveredAliveCAM+Yes1724Yes4NoneHeart/lung*Staphylococcus aureus*AliveCAM+Yes1819Yes5IVDU, Hep CBacteremiaGNBDeadCAM+Yes2226Yes6NoneAbdomenNone recoveredAliveCAM+No1015Yes7Pancreatitis, EtOH, DM2AbdomenNone recoveredAliveCAM−No816Yes8Smoker, AsthmaLungNone recoveredAliveCAM−No1518Yes9DM2, HTN, IHD, UGIBLung*Pseudomonas* sp.AliveCAM−Yes1530Yes10NoneLungNone recoveredAliveCAM−No69No11DM2, CMP, COPDIschemic foot*S. aureus*DeadCAM+Yes2026Yes12CHF, CRI, RANecrotizing fasciitisPseudomonasDeadCAM−Yes1923Yes13DM2, PVDLegβ-hemolytic strepAliveCAM−Yes1321Yes14Developmental delayAbdomenNon-hemolytic StreptococcusAliveCAM−Yes1227Yes15Autoimmune hepatitis, portal HTN, ESRDAnkleNone recoveredAliveCAM+No1623No*PMHx* past medical history, *CAM*-*ICU* confusion assessment method, *AKI* acute kidney injury, *EtOh* ethanol, *HIV* human immunodeficiency virus, *IHD* ischemic heart disease, *CHF* congestive heart failure, *IVDU* intravenous drug use, *HEP C* hepatitis C virus, *DM2* type 2 diabetes, *HTN* hypertension, *UGIB* upper gastrointestinal bleed, *CMP* cardiomyopathy, *COPD* chronic obstructive pulmonary disease, *CRI* chronic renal insufficiency, *RA* rheumatoid arthritis, *PVD* peripheral vascular disease, *ESRD* end-stage renal diseaseTable 2Baseline demographics, co-morbidities, and type of surgery performed for the septic and surgical patientsBaseline demographicsSeptic patientsSurgicalNumber studied1530Age56.9 ± 14.071.4 ± 6.4Male6/1520/30Co-morbiditiesHypertension418Angina04Previous myocardial infarct17Congestive heart failure30Ethanol abuse20HIV infection10Hepatitis C infection10Diabetes45Chronic renal insufficiency21Chronic obstructive pulmonary disease22Type of surgery performed Vascular9 General surgery6 Thoracic13 Urologic2

Patients in the septic shock group were monitored for an average of 39.8 ± 20.4 h. Twelve (80 %) of the septic shock patients had a decrease in their SctO~2~ to below 65 %. Six had decreases in their SctO~2~ to below 60 %.

There was no difference between the CAM-ICU positive and CAM-ICU negative groups with respect to the percentage of time spent below an SctO~2~ of 65 % nor the area under a threshold SctO~2~ of 65 % (see Table [3](#Tab3){ref-type="table"}, all *p* values \> 0.05).Table 3Relationship between magnitude of cerebral desaturation and primary and secondary outcomesOutcomeOutcome presentOutcome absent*p* valueCAM positive % Time0.0 \[0.0--1.5\]0.0 \[0.0--0.3\]0.79 AUT/h2.9 \[0.2--8.4\]9.3 \[1.2--16.0\]0.41AKI % Time2.0 \[0.7--6.3\]2.1 \[0.8--21.5\]0.51 AUT/h2.9 \[0.2--8.4\]12.6 \[0.3--21.2\]0.59Death % Time0.9 \[0.0--7.2\]0.0 \[0.0--0.3\]0.43 AUT/h4.5 \[0.0--25.3\]0.0 \[0.0--0.6\]0.04There was no difference in SctO~2~ between groups with respect to the presence of acute kidney injury (AKI) nor being Confusion Assessment Method (CAM-ICU) positive. Patients who died had decreases in SctO~2~ of greater magnitude than those that survived. Data are presented as median \[interquartile range\]. Values are represented as median \[interquartile range\]*% Time* percentage of time spent below an SctO~2~ of 65 %*AUT* area under threshold (% min^−1^ hr^−1^)

There was also no difference in the percentage of time spent below an S~ct~O~2~ of 65 % in patients who did and did not suffer an AKI. The AUT of an S~ct~O~2~ \< 65 % was also not different between the patients with and without an AKI (Table [3](#Tab3){ref-type="table"}).

Patients who died during the study, however, had a lower median AUT S~ct~O~2~ \< 65 % than patients who survived (4.5 \[0.0--25.3\] vs. 0.0 \[0.0--0.6\] % min^−1^ hr^−1^; *p* = 0.04; Table [3](#Tab3){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}). There was no difference in the percentage time spent under a threshold of 65 % between patients who survived and died, suggesting that it is the magnitude of desaturation that plays an important role in this outcome (Table [3](#Tab3){ref-type="table"}).Fig. 1Graphical representation of the Log AUT SctO~2~ of patients who died and survived their septic shock. Patients who died had a higher median AUT S~ct~O~2~ \< 65 % than patients who survived (4.5 \[0.0--25.3\] vs. 0.0 \[0.0--0.6\] % min^−1^ hr^−1^; *p* = 0.04)

The incidence or magnitude of decrease in SctO~2~ was not related to the severity of the patient's illness, as measured by SOFA or APACHE II scores (data not shown).

With respect to the variables that may affect cerebral blood flow (and therefore potentially cerebral saturation), there was no correlation between S~ct~O~2~ and peripheral oxygen saturation, norepinephrine dose, mean arterial pressure (MAP), or fraction of inspired oxygen (F~I~O~2~) (Fig. [2a--c](#Fig2){ref-type="fig"}). However, there was a correlation between day 2 hemoglobin concentrations and both the percentage time below an S~ct~O~2~ (Pearsons *r* = −0.46, Fig. [3a](#Fig3){ref-type="fig"}) and SctO~2~ AUT \< 75 % (Pearsons *r* = −0.55, Fig. [3b](#Fig3){ref-type="fig"}), with lower hemoglobin values being associated with more significant cerebral desaturations.Fig. 2Correlation between SctO~2~ values and **a** mean arterial pressure, **b** norepinephrine dose, and **c** peripheral oxygen saturation. There was no correlation between any of these variables and SctO~2~ (Pearsons *r*)Fig. 3Correlation between **a** percent time below and **b** AUT below a SctO~2~ of 75 % and post intensive care unit admission day 2 hemoglobin. Decreases in hemoglobin concentration were correlated with both the duration (Pearsons *r* = −0.46) and magnitude (Pearsons *r* = −0.41) of cerebral desaturations

As a comparison group, we also looked the incidence and magnitude of decreases of cerebral saturation in 30 patients undergoing high-risk non-cardiac surgical procedures, a group known to be at high risk for decreases in SctO~2~. The surgical patients were significantly older (71 ± 6 vs. 57.0 ± 3.6 years, *p* \< 0.001) and were coming for a variety of high-risk procedures (see Table [2](#Tab2){ref-type="table"}).

Nine of the surgical patients (30 %) experienced a decrease in their SctO~2~ to below 65 %. Patients in the septic shock group were significantly more likely to experience a cerebral desaturation than those in the surgical group (12/15 vs. 9/30; relative risk 2.7 \[95 % CI 1.5--4.9\], *p* \< 0.01; Table [4](#Tab4){ref-type="table"}). The patients with septic shock also spent more time below an SctO~2~ threshold of 65 % when compared with the patients undergoing high-risk surgery (2.2 % \[0.9--10.9\] vs. 0.0 % \[0.0--8.8\], *p* = 0.03, septic vs. surgical patients, respectively, see Table [4](#Tab4){ref-type="table"}). The septic patients also had a greater magnitude of cerebral desaturation (based on AUT calculation) when compared with the surgical patients (3.1 \[0.3--14.5\] vs. 0.0 \[0.0--6.9\] % min^−1^ hr^−1^; *p* \< 0.05, septic vs. surgical, respectively, see Table [4](#Tab4){ref-type="table"}).Table 4Comparison of cerebral saturation between septic and surgical patientsParameterSepticSurgical*p* valueNumber of patients with desaturations12/159/30\< 0.01Percent time below SctO~2~ threshold2.2 \[0.9--10.9\]0 \[0.0--8.8\]0.03AUT/h3.1 \[0.3--14.5\]0.0 \[0.0--6.9\]0.04Septic patients had decreases in their SctO~2~ more frequently and of a greater magnitude than surgical patients. Data are presented as median \[interquartile range\]. The number of patients with desaturations was compared using Fisher's exact test, while percent time and AUT/Hr differences were compared with Mann-Whitney *U* test*Percent time* percentage of time spent below an SctO~2~ of 65 %*AUT* area under threshold (% min^−1^ hr^−1^)

Discussion {#Sec6}
==========

Our study did not demonstrate any relationship between decreases in SctO~2~ and the incidence of delirium in patients admitted to the ICU with septic shock. We chose the S~ct~O~2~ threshold of 65 % as constituting a significant cerebral desaturation, based on work by other authors \[[@CR10], [@CR22]--[@CR24]\]. We also did not demonstrate any relationship between decreases in SctO~2~ and the development of an AKI. We did however discover that patients who died from their septic shock had significantly larger decreases in their SctO~2~ compared with those who survived.

The lack of an association between decreases in SctO~2~ and delirium could potentially be due to several factors. First, the etiology of delirium is multifactorial, and exact causes of it are uncertain. Second, most of our patients received benzodiazepines, a class of drugs that has been associated with postoperative delirium \[[@CR25]\]. Finally, the cerebral oximeter we used only measures SctO~2~ from the frontal lobes and would not detect desaturations that take place in deeper cortical structures. Thus, we might be missing changes in SctO~2~ that occur in deeper parts of the brain that could predispose patients to delirium.

In our study, patients who died from septic shock had larger decreases in their SctO~2~ when compared with those patients who survived. Due to the small number of patients studied, it is possible that this is a spurious finding. There is biological plausibility, however, for decreases in SctO~2~ being linked to death.

Animal studies have demonstrated that as global oxygen delivery is reduced, blood flow and therefore oxygen delivery to the brain is preserved \[[@CR15]\]. This may explain the association between decreases in SctO~2~ and non-neurologic organ injury. The brain can be considered the organ of highest priority when it comes to tissue hypoperfusion during shock states. When oxygen delivery to the brain is decreased below a critical value, cerebral desaturations occur. In the context of septic shock, cerebral desaturation likely indicates that blood flow to the other vital organs has been severely compromised. Our work suggests that non-survivors of septic shock exhibit decreased SctO~2~ as a reflection of more severe global perfusion defects compared to survivors. Our study is obviously too small to confirm this, but is hypothesis generating.

When compared with a group of high-risk patients undergoing major non-cardiac surgery at our institution, patients with septic shock had a higher incidence and greater magnitude of cerebral desaturations. We chose high-risk surgical patients as a comparator group as it is known that these patients have high rates of cerebral desaturation and are at high risk for complications. The incidence of cerebral desaturations in our surgical patients is consistent with previous studies that showed a cerebral desaturation incidence of 20--30 % in patients undergoing elective non-cardiac surgery \[[@CR10], [@CR12], [@CR17], [@CR22], [@CR23]\]. Our findings suggest that cerebral desaturations are more common and more severe in septic shock patients.

Other interesting findings from our study are the lack of relationship between SctO~2~ and peripheral oxygen saturation, F~I~O~2~, MAP, or vasopressor dose. With the knowledge that decreases in SctO~2~ are related to the outcome, there have been proposed treatment strategies to increase SctO~2~ in the hopes of improving the outcome \[[@CR26]\]. These strategies include increasing MAP, increasing arterial carbon dioxide tension (to increase cerebral blood flow), increasing F~I~O~2~, and increasing hemoglobin concentration with red blood cell transfusions. Our work suggests that, in septic patients, these variables (with the exception of hemoglobin concentration) do not correlate with cerebral saturation.

Other perioperative studies have pointed to anemia as a potential cause of adverse neurological outcomes \[[@CR27]\]. However, the literature regarding the beneficial effects of blood transfusion in critical care is controversial, with the most recent study suggesting no benefit of higher hemoglobin levels in septic patients \[[@CR28]--[@CR30]\].

Limitations to our study include the small number of patients studied and the varying etiologies of sepsis and the different baseline co-morbidities. A much larger study will have to be undertaken to determine if there is truly no relationship between cerebral desaturations and delirium.

Finally, the issue of extracranial contamination might have affected our results \[[@CR31]\]. Briefly, extracranial contamination occurs when desaturated blood below the skin is measured by the device and interpreted as being intracranial in nature. With the aggressive fluid resuscitation that our patients were receiving, it is possible that the edema that results from fluid administration might have resulted in spuriously lower levels of measured SctO~2~.

Conclusions {#Sec7}
===========

Our study suggests that decreases in SctO~2~ occur frequently in patients with septic shock. These decreases are of a larger magnitude than in a group of patients undergoing high-risk non-cardiac surgery. Decreases in SctO~2~ are not related to ICU delirium, but may be related to the risk of death in the ICU. Finally, there appears to be no relationship between the incidence or magnitude of decreases in SctO~2~ and physiological parameters (such as F~I~O~2~, MAP, or vasopressor dose). However, decreases in hemoglobin concentration appear to correlate with changes in SctO~2~.
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